FTNT vs TERN · P/E 56, rev $6.80B vs $6.12B cap
Fortinet Inc (FTNT) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
FTNT currently screens at market cap $105.60B and trailing P/E 56.1. TERN currently screens at market cap $6.12B.
Not investment advice. Open the FTNT and TERN stock pages for the full models.
Not investment advice.